115 related articles for article (PubMed ID: 25546551)
1. Lipoic-based TRPA1/TRPV1 antagonist to treat orofacial pain.
Gualdani R; Ceruti S; Magni G; Merli D; Di Cesare Mannelli L; Francesconi O; Richichi B; la Marca G; Ghelardini C; Moncelli MR; Nativi C
ACS Chem Neurosci; 2015 Mar; 6(3):380-5. PubMed ID: 25546551
[TBL] [Abstract][Full Text] [Related]
2. Activation of transient receptor potential ankyrin 1 by eugenol.
Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.
Banke TG; Chaplan SR; Wickenden AD
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1457-68. PubMed ID: 20457836
[TBL] [Abstract][Full Text] [Related]
4. Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity.
Miyano K; Minami K; Yokoyama T; Ohbuchi K; Yamaguchi T; Murakami S; Shiraishi S; Yamamoto M; Matoba M; Uezono Y
Anesth Analg; 2015 Apr; 120(4):790-8. PubMed ID: 25642661
[TBL] [Abstract][Full Text] [Related]
5. Transient receptor potential ion channels: powerful regulators of cell function.
Billeter AT; Hellmann JL; Bhatnagar A; Polk HC
Ann Surg; 2014 Feb; 259(2):229-35. PubMed ID: 23989052
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 and TRPV1 activation is a novel adjuvant effect mechanism in contact hypersensitivity.
Shiba T; Maruyama T; Kurohane K; Iwasaki Y; Watanabe T; Imai Y
J Neuroimmunol; 2009 Feb; 207(1-2):66-74. PubMed ID: 19135264
[TBL] [Abstract][Full Text] [Related]
7. TRPA1 mediates the effects of hypothermia on the monocyte inflammatory response.
Billeter AT; Galbraith N; Walker S; Lawson C; Gardner SA; Sarojini H; Galandiuk S; Polk HC
Surgery; 2015 Sep; 158(3):646-54. PubMed ID: 26054320
[TBL] [Abstract][Full Text] [Related]
8. TRPA1 contributes to capsaicin-induced facial cold hyperalgesia in rats.
Honda K; Shinoda M; Furukawa A; Kita K; Noma N; Iwata K
Eur J Oral Sci; 2014 Dec; 122(6):391-6. PubMed ID: 25371244
[TBL] [Abstract][Full Text] [Related]
9. Hydroxy-alpha-sanshool activates TRPV1 and TRPA1 in sensory neurons.
Koo JY; Jang Y; Cho H; Lee CH; Jang KH; Chang YH; Shin J; Oh U
Eur J Neurosci; 2007 Sep; 26(5):1139-47. PubMed ID: 17767493
[TBL] [Abstract][Full Text] [Related]
10. Activation of TRPV1 and TRPA1 by black pepper components.
Okumura Y; Narukawa M; Iwasaki Y; Ishikawa A; Matsuda H; Yoshikawa M; Watanabe T
Biosci Biotechnol Biochem; 2010; 74(5):1068-72. PubMed ID: 20460725
[TBL] [Abstract][Full Text] [Related]
11. Activation of TRPA1 by farnesyl thiosalicylic acid.
Maher M; Ao H; Banke T; Nasser N; Wu NT; Breitenbucher JG; Chaplan SR; Wickenden AD
Mol Pharmacol; 2008 Apr; 73(4):1225-34. PubMed ID: 18171730
[TBL] [Abstract][Full Text] [Related]
12. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
[TBL] [Abstract][Full Text] [Related]
14. Identification of natural compound carnosol as a novel TRPA1 receptor agonist.
Zhai C; Liu Q; Zhang Y; Wang S; Zhang Y; Li S; Qiao Y
Molecules; 2014 Nov; 19(11):18733-46. PubMed ID: 25405290
[TBL] [Abstract][Full Text] [Related]
15. Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists.
Klionsky L; Tamir R; Gao B; Wang W; Immke DC; Nishimura N; Gavva NR
Mol Pain; 2007 Dec; 3():39. PubMed ID: 18086308
[TBL] [Abstract][Full Text] [Related]
16. Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1.
Spahn V; Stein C; Zöllner C
Mol Pharmacol; 2014 Feb; 85(2):335-44. PubMed ID: 24275229
[TBL] [Abstract][Full Text] [Related]
17. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity.
Eid SR; Crown ED; Moore EL; Liang HA; Choong KC; Dima S; Henze DA; Kane SA; Urban MO
Mol Pain; 2008 Oct; 4():48. PubMed ID: 18954467
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy.
Koivisto A; Hukkanen M; Saarnilehto M; Chapman H; Kuokkanen K; Wei H; Viisanen H; Akerman KE; Lindstedt K; Pertovaara A
Pharmacol Res; 2012 Jan; 65(1):149-58. PubMed ID: 22133672
[TBL] [Abstract][Full Text] [Related]
19. Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
Schenkel LB; Olivieri PR; Boezio AA; Deak HL; Emkey R; Graceffa RF; Gunaydin H; Guzman-Perez A; Lee JH; Teffera Y; Wang W; Youngblood BD; Yu VL; Zhang M; Gavva NR; Lehto SG; Geuns-Meyer S
J Med Chem; 2016 Mar; 59(6):2794-809. PubMed ID: 26942860
[TBL] [Abstract][Full Text] [Related]
20. Enhanced activation of the transient receptor potential channel TRPA1 by ajoene, an allicin derivative.
Yassaka RT; Inagaki H; Fujino T; Nakatani K; Kubo T
Neurosci Res; 2010 Jan; 66(1):99-105. PubMed ID: 19808063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
